Financials data is unavailable for this security.
View more
Year on year Quest Diagnostics Inc grew revenues 11.78% from 9.87bn to 11.04bn while net income improved 13.89% from 871.00m to 992.00m.
| Gross margin | 33.32% |
|---|---|
| Net profit margin | 9.10% |
| Operating margin | 14.10% |
| Return on assets | 6.20% |
|---|---|
| Return on equity | 14.17% |
| Return on investment | 7.25% |
More ▼
Cash flow in USDView more
In 2025, cash reserves at Quest Diagnostics Inc fell by 129.00m. However, the company earned 1.89bn from its operations for a Cash Flow Margin of 17.09%. In addition the company used 631.00m on investing activities and also paid 1.39bn in financing cash flows.
| Cash flow per share | 13.96 |
|---|---|
| Price/Cash flow per share | 14.36 |
| Book value per share | 65.18 |
|---|---|
| Tangible book value per share | -31.01 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.04 |
|---|---|
| Quick ratio | 0.9609 |
| Total debt/total equity | 0.7909 |
|---|---|
| Total debt/total capital | 0.4377 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 1.86% |
|---|---|
| Div growth rate (5 year) | 7.68% |
| Payout ratio (TTM) | 27.33% |
| EPS growth(5 years) | -3.55 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 14.60 |
More ▼
